Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PinnacleXon Mar 30, 2022 4:28pm
70 Views
Post# 34560485

RE:More on Reverse Splits

RE:More on Reverse Splits
SPCEO1 wrote: Here is an article presented by NASDAQ late last eyar on reverse splits:

https://www.nasdaq.com/articles/the-impact-of-reverse-splits-on-low-priced-stocks-2021-10-28

Here are a couple of points from the article in case you don't have time to read the whole thing:

The data shows that the market cap of the median split also falls slightly, but some research suggests that’s due to weaker fundamentals in those low-priced stocks. We would highlight that those stocks that voluntarily reverse split closer to their “perfect” price (which we talk about more below) perform better than other reverse splits.

Notably, that is consistent with other academic research that finds that stocks generally drift downward post-reverse-split. However, the downward drift doesn’t appear to be extreme enough to erode the benefits of
completing the reverse split initially.


This article highlights the advantages from tradability of doing a reverse split.

Obviously, many reverse splits are done by junk companies and the results are, as many here and TH's CFO, fear. But TH is not a junk company so those fears are unjustified. 



LOL now your on to Reverse slipts, well I have to give it to you, I never thought of it as all else was already used up by you.  Im curious as to what youre gonna come up with when this garbage is at .15 cents after everything has failed(almost everything already has)
<< Previous
Bullboard Posts
Next >>